EFFICACY AND SAFETY OF SECUKINUMAB IN JUVENILE IDIOPATHIC ARTHRITIS: INTERIM RESULTS FROM THE EXTENSION OF THE JUNIPERA TRIAL

被引：1

作者：

Ruperto, N. ^{[1
]}

Foeldvari, I. ^{[2
]}

Alexeeva, E. ^{[3
]}

Ayaz, N. Aktay ^{[4
]}

Schulert, G. ^{[5
]}

Ozen, S. ^{[6
]}

Popov, A. ^{[7
]}

Ramanan, A. ^{[8
]}

Scott, C. ^{[9
]}

Sozeri, B. ^{[10
]}

Zholobova, E. ^{[11
]}

Chakraborty, S. ^{[12
]}

Zhu, X. ^{[13
]}

Martin, R. ^{[14
]}

Whelan, S.

Kaur, S. ^{[15
]}

Pricop, L. ^{[13
]}

Lovell, D. J. ^{[5
]}

Martini, A. ^{[16
]}

Brunner, H. ^{[5
]}

机构：

[1] IRCCS Ist Giannina Gaslini, UOSID Ctr Trial, Genoa, Italy

[2] Hamburger Zentrum fuer Kinder & Jugendrheumatol, Rheumatol, Hamburg, Germany

[3] Natl Sci & Pract Ctr Childrens Hlth, Rheumatol, Moscow, Russia

[4] Istanbul Univ Cerrahpasa, Pediat Rheumatol, Fac Med, Istanbul, Turkiye

[5] Univ Cincinnati, Cincinnati Childrens Hosp, UC Dept Pediat, Cincinnati, OH USA

[6] Hacettepe Univ, Rheumatol, Med Fac, Ankara, Turkiye

[7] Ural State Med Univ Ekaterinburg, Rheumatol, Ekaterinburg, Russia

[8] Univ Bristol, Bristol Royal Hosp Children & Translat Hlth Sci, Bristol, Avon, England

[9] Univ Cape Town, Red Cross War Mem Childrens Hosp, Paediat Rheumatol, Cape Town, South Africa

[10] Univ Hlth Sci, Umraniye Training & Res Hosp, Div Pediat Rheumatol, Istanbul, Turkiye

[11] First Moscow State Med Univ, Moscow, Russia

[12] IQVIA, Durrham, NC USA

[13] Novartis Pharmaceut, E Hanover, NJ USA

[14] Novartis Ireland Ltd, Immunol, Dublin, Ireland

[15] Novartis Pharma AG, Immunol, Basel, Switzerland

[16] Univ Genoa, Rheumatol, Genoa, Italy

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷

关键词：

bDMARD; Clinical Trials;

D O I：

10.1136/annrheumdis-2023-eular.3679

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS0278

引用

页码：379 / 380

页数：2

共 50 条

[31] Predicting Extension in Juvenile Idiopathic Arthritis
Simonds, Megan
Sullivan, Kathleen
Brescia, AnneMarie
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 151 - 152
[32] Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study
Buch, Maya H.
Aletaha, Daniel
Combe, Bernard G.
Tanaka, Yoshiya
Caporali, Roberto
Schulze-Koops, Hendrik
Takeuchi, Tsutomu
Gottenberg, Jacques-Eric
Blanco, Ricardo
Verschueren, Patrick
Zubrzycka-Sienkiewicz, Anna
De Leonardis, Francesco
Omoruyi, Edmund V. Ekoka
Rajendran, Vijay
Emery, Paul
RMD OPEN, 2024, 10 (04):
[33] Switching from Reference to Biosimilars Does Not Reduce Efficacy and Safety in Juvenile Idiopathic Arthritis
Maccora, Ilaria
Simonini, Gabriele
Bettiol, Alessandra
Pagnini, Ilaria
Lombardi, Niccolo
Maniscalco, Valerio
Crescioli, Giada
Marrani, Edoardo
Bonaiuti, Roberto
Mastrolia, Maria Vincenza
Ravaldi, Claudia
Vannacci, Alfredo
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[34] Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study
Brunner, Hermine I.
Akikusa, Jonathan D.
Al-Abadi, Eslam
Bohnsack, John F.
Boteanu, Alina Lucica
Chedeville, Gaelle
Cuttica, Ruben
De La Pena, Wendy
Jung, Lawrence
Kasapcopur, Ozgur
Kobusinska, Katarzyna
Schulert, Grant S.
Neiva, Claudia
Rivas-Chacon, Rafael
Rizo Rodriguez, Juan Cruz
Vazquez-Del Mercado, Monica
Wagner-Weiner, Linda
Weiss, Jennifer E.
Wouters, Carine
Posner, Holly
Wouters, Ann
Chang, Cheng
White, Claire
Kanik, Keith
Liu, Shixue
Martini, Alberto
Lovell, Daniel J.
Ruperto, Nicolino
ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (11) : 1561 - 1571
[35] An Open-Label Trial to Assess the Efficacy and Safety of Tocilizumab in the Management of Juvenile Idiopathic Arthritis-Associated Uveitis: Preliminary Results
Suhler, Eric B.
Giles, Tracy R.
Lin, Phoebe
Shifera, Amde Selassie
Rosenbaum, James T.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
[36] Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry
Lovell, Daniel J.
Tzaribachev, Nikolay
Henrickson, Michael
Simonini, Gabriele
Griffin, Thomas A.
Alexeeva, Ekaterina
Bohnsack, John F.
Zeft, Andrew
Horneff, Gerd
Vehe, Richard K.
Stanevica, Valda
Tarvin, Stacey
Trachana, Maria
del Rio, Ana Quintero
Huber, Adam M.
Kietz, Daniel
Orban, Ilonka
Dare, Jason
Foeldvari, Ivan
Quartier, Pierre
Dominique, Alyssa
Simon, Teresa A.
Martini, Alberto
Brunner, Hermine, I
Ruperto, Nicolino
RHEUMATOLOGY, 2024,
[37] Safety and effectiveness of etanercept for treatment of juvenile idiopathic arthritis: Results from a postmarketing surveillance
Mori, Masaaki
Sugiyama, Naonobu
Morishima, Yosuke
Sugiyama, Noriko
Kokubo, Takeshi
Takei, Syuji
Yokota, Shumpei
MODERN RHEUMATOLOGY, 2018, 28 (01) : 101 - 107
[38] Efficacy and safety of tocilizumab in Chinese patients with systemic juvenile idiopathic arthritis: a multicentre phase IV trial
Li, Caifeng
Tang, Xuemei
Zhou, Zhixuan
Sun, Li
Lu, Meiping
Zhou, Wei
Yang, Sirui
Zheng, Wenjie
Yu, Haiguo
Tan, Weiping
Zhang, Junmei
Zhang, Yu
Kong, Yuxiu
Xu, Jiahui
CLINICAL RHEUMATOLOGY, 2024, 43 (11) : 3457 - 3467
[39] Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study
Brunner, Hermine, I
Quartier, Pierre
Alexeeva, Ekaterina
Constantin, Tamas
Kone-Paut, Isabelle
Marzan, Katherine
Schneider, Rayfel
Wulffraat, Nico M.
Chasnyk, Vyacheslav
Tirosh, Irit
Kallinich, Tilmann
Kuemmerle-Deschner, Jasmin
Wouters, Carine
Lauwerys, Bernard
Nikishina, Irina
Trachana, Maria
Vougiouka, Olga
Martini, Alberto
Lovell, Daniel J.
Levy, Jeremy
Vritzali, Eleni
Ruperto, Nicolino
ARTHRITIS & RHEUMATOLOGY, 2020, 72 (12) : 2147 - 2158
[40] The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis
SA Alfantaki
S Stavrou
A Siamopoulou-Mavridou
Pediatric Rheumatology, 9 (Suppl 1)

← 1 2 3 4 5 →